Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
RDT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

29 May 2019 07:00

RNS Number : 3815A
Rosslyn Data Technologies PLC
29 May 2019
 

29 May 2019

Rosslyn Data Technologies plc

("RDT" the "Group")

Trading Update

Rosslyn Data Technologies plc (AIM: RDT), a leading global big data technology company, is pleased to issue the following trading statement in advance of its results announcement for the year ended 30 April 2019, which is scheduled to be released in September.

Following the integration of Integritie, which was completed early last year, this year has been one of consolidation, resulting in investment into product development, further reducing costs, and pursuing larger value contracts with a broader product offering.

It is expected that results for the Group will show Revenue growth of 8.3% to £7.0 million (2018: £6.4 million). Underlying Annual Licence Fee revenue is expected to show growth of 9.2% to £5.4 million (2018: £5.0 million) and Operating EBITDA (excluding share-based costs) improving by 75% to a loss of £432,000 (2018: loss of £1.8 million). The Group was pleased to have achieved a key milestone, having generated cash from operations of £329,000 (2018: Cash used in operations of £3.45 million).

Investment into research and development amounted to £0.9 million (2018: £1.1 million). The Group's policy is to fully expense these costs as they are incurred and excluding this investment the Operating EBITDA would have been a profit of £0.5 million (2018: loss of £0.7 million).

Excluding bank debt, the cash balance at the year-end was £2.0 million (2018: £0.3 million). During the year we secured a £1.5 million term loan from Clydesdale Bank of which £1.0 million had been drawn down at the year end. Part of this drawdown was used in April and May 2019 to repay loan notes taken on in the acquisition of Integritie totalling £134,000 and £626,000 respectively.

Our cost base reduced during the year, with Operating expenditure of £6.0 million (2018: £6.7 million) and the Group will continue to focus on costs. We have a product suite that we believe makes a material difference to our clients' operations and, in order to achieve greater penetration and accelerate our growth, we intend to invest into Sales and Marketing this year.

We have invested in product development to broaden out the RAPid product offering, adding new tools and functionality and also fully integrating functionality from the Integritie product suite. This will allow us to provide greater value to clients by being more embedded into their systems and processes.

During the year, we secured numerous high value contracts in various sectors including International Logistics, Civil Defence, Healthcare and Pharma. This illustrates the broad appeal of our offering across the Supply Chain to Chief Procurement Officers and Chief Financial Officers in a wide range of sectors. The Group is in discussions regarding contracts with additional high value blue chip targets in the current year which, while they take longer to negotiate, and their timing is harder to predict, would provide upside to the Group.

We believe that this year of consolidation is important in allowing us to accelerate growth in the coming years from a sound base. With an enhanced board, a focussed team and an advanced suite of products to address a market that is much more aware of the opportunities presented by data analytics, the Group is well positioned as it enters the current financial year.

 

Rosslyn Chief Executive Officer, Roger Bullen said;

"This year we have been able to grow our top line revenues, particularly licence fees, reduce our cost base and, most importantly, generate cash during the year, all whilst maintaining excellent service delivery to our clients. The growth in the RAPid platform, which now fully utilises the suite of products purchased in May 2017, enables us to offer our clients a broader solution to benefit from their difficult to reach supply chain data."

 

This announcement contains inside information.

 

 

Rosslyn Data Technologies plc

Roger Bullen, Chief Executive Officer

+44(0)77 7162 3345+44(0)20 7138 3203

Ash Mehta, Chief Financial Officer

+44(0)79 3054 7441+44(0)20 7138 3203

Cenkos Securities,Nominated Adviser, Broker

Stephen Keys/Giles Balleny

 

+44(0)20 7397 8924

 

Notes to Editors

Rosslyn Data Technologies plc, (AIM: RDT) is a leading provider of a cloud-based big-data analytics platform. The company provides analytical services by combining four key technologies: bulk data extraction; cleansing; enrichment; and visualisation, through a single cloud platform enabling users with detailed data to make more informed decisions. Rosslyn's RAPid platform is the Group's primary product available to its multinational customers.

Further information can also be found on the Company's website at: www.rosslyndatatech.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKFDKABKDBPB
Date   Source Headline
12th Jan 20235:24 pmRNSHolding(s) in Company
14th Dec 20224:16 pmRNSGrant of Options
6th Dec 20221:37 pmRNSResult of Annual General Meeting
11th Nov 20224:24 pmRNSNotice of Annual General Meeting
7th Nov 20227:00 amRNSTwo Contract Wins
1st Nov 202211:06 amRNSSecond Price Monitoring Extn
1st Nov 202211:02 amRNSSale of Integritie
1st Nov 202211:00 amRNSPrice Monitoring Extension
31st Oct 20224:51 pmRNSPublication of Annual Report
31st Oct 20223:07 pmRNSFinal Results
10th Oct 20224:41 pmRNSSecond Price Monitoring Extn
10th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSSale of Langdon Systems
29th Sep 20227:00 amRNSRosslyn wins £500k contract
22nd Aug 20227:00 amRNSFirst contract secured with Chain IQ
2nd Aug 20222:30 pmRNSInvestor Webinar
29th Jun 20227:00 amRNSBusiness Update
31st Jan 20227:00 amRNSHalf-year Report
14th Jan 20229:05 amRNSSecond Price Monitoring Extn
14th Jan 20229:00 amRNSPrice Monitoring Extension
13th Jan 20227:00 amRNSTrading Statement
28th Oct 20214:15 pmRNSResult of AGM
4th Oct 20219:34 amRNSAnnual Report and AGM Notice
30th Sep 20217:00 amRNSFinal Results
13th Sep 20211:59 pmRNSHolding(s) in Company
16th Aug 202111:27 amRNSGrant of Options
5th Jul 20217:00 amRNSDirectorate Change
4th Jun 20217:00 amRNSBoard Change
4th Jun 20217:00 amRNSTrading Update
6th Apr 20217:00 amRNSDirectorate Change
23rd Mar 20215:54 pmRNSExercise of Options
4th Mar 20217:00 amRNSChange of auditor
12th Jan 20217:00 amRNSHalf-year Report
21st Dec 20207:00 amRNSLaunch of CustomsCloudTM product
11th Nov 20207:00 amRNSContract Win
29th Oct 20204:45 pmRNSResult of AGM
30th Sep 20209:20 amRNSNotice of AGM
29th Sep 202010:15 amRNSHolding(s) in Company
28th Sep 20204:33 pmRNSChange of Registered Office
25th Sep 202012:01 pmRNSIssue of Equity
24th Sep 20207:00 amRNSDirector/PDMR Dealing
22nd Sep 20207:00 amRNSAudited Results for the year ended 30 April 2020
1st Sep 20207:00 amRNSBoard Update
28th Aug 20204:42 pmRNSHolding(s) in Company
17th Aug 20207:00 amRNSAppointment of Chief Customer Officer
11th Aug 20209:06 amRNSSecond Price Monitoring Extn
11th Aug 20209:01 amRNSPrice Monitoring Extension
7th Jul 20207:00 amRNSStrengthening client relationships during COVID-19
25th Jun 20207:00 amRNSContract Renewals
16th Jun 20209:01 amRNSDirector/PDMR Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.